RJFSA

Raymond James Financial Services Advisors’s ARS Pharmaceuticals SPRY Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$1.14M	Buy	78,779 +68,329	+654%	+$991K	﹤0.01%	2079
2024 Q2	$88.9K	Buy	+10,450	New	+$88.9K	﹤0.01%	3245
2023 Q1	–	Sell	-16,742	Closed	-$143K	–	3349
2022 Q4	$143K	Buy	+16,742	New	+$143K	﹤0.01%	2944